Search for: "Pfizer, A Delaware Corporation" Results 41 - 60 of 69
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2010, 7:49 am by Broc Romanek
Supermajority Provisions As of Feb. 15, investors had filed 26 proposals that seek to repeal supermajority requirements to approve bylaws, corporate transactions, and other matters. [read post]
1 Mar 2010, 7:11 pm
(Patently-O) District Court Delaware: Federal Circuit’s en banc review of written description requirement does not constitute ‘intervening change’ or alter ‘existing standards’: Cordance Corporation v. [read post]
1 Mar 2010, 7:11 pm
(Patently-O) District Court Delaware: Federal Circuit’s en banc review of written description requirement does not constitute ‘intervening change’ or alter ‘existing standards’: Cordance Corporation v. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/14: Daiichi Sankyo Inc.and Genzyme Corporation v. [read post]
3 Feb 2010, 9:39 pm by Andrew Russell
In this particular case Pfizer, a Delaware corporation with its principal place of business in New York, brought an ANDA suit against Sandoz, Inc., a Colorado corporation with its principal place of business in New Jersey, but also with its primary manufacturing plant located in Colorado. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Sharp Corporation, Sharp Electronics Corporation and Sharp Electronics Manufacturing Company of America Inc. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/23: Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company, LLC v. [read post]
30 Oct 2009, 6:04 am
The stated purpose for this inspection was apparently to investigate possible waste or mismanagement, a traditionally accepted basis for inspection under Section 220 of the Delaware General Corporation Law. [read post]
21 Oct 2009, 4:22 am
Pfizer-style) and several directors do not receive a majority of the vote in the election, the board's subsequent rejection of the directors' resignation letters is not, by itself, enough to serve as a credible basis of wrongdoing in a books and records request brought under Section 220 of the Delaware General Corporation Law. [read post]
9 Oct 2009, 9:11 am
Actavis Elizabeth LLC, Anchen Pharmaceuticals Inc. and Anchen Incorporated (patent infringement) 10/6: Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV v. [read post]
28 Sep 2009, 9:21 am
This is the first Delaware decision to deal with the so-called Pfizer policy on when directors may be retained despite a shareholder vote on dissatisfaction. [read post]
21 Jul 2009, 5:00 am
  The provision (contained in the Company's Corporate Governance Principles) can be found here. [read post]
2 Jun 2009, 5:39 am
According to this complaint filed in the Delaware Chancery Court against Axcelis Technologies, a municipal pension fund has demanded to inspect the company â [read post]
2 Dec 2008, 7:05 pm
Indeed, the main reason for starting in corporate, securities and finance is because most transactions in those areas are governed by New York, Delaware and federal law which makes it a bit more manageable from the outset. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Jul 2008, 11:05 am
: (Intellectual Property Watch), Why compulsory licenses are bad: a look at the sausage making process: (Techdirt) More on ACTA: (LawFont.com) Global - Trade Marks / Domain Names / Brands Brand Finance 500: the annual report on the world’s most valuable brands: (IP finance), Gretchen Olive’s ‘10 steps to an effective domain name policy’: (IPwar’s), ICANN approves GNSO proposals imposing financial penalty on registrars who engage in excessive domain… [read post]